11 Recruiting Melanoma Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for melanoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Melanoma studiesPhase 1 / Phase 2 Studies for Melanoma
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
📍 The Angeles Clinic and Research Institute - California — Los Angeles, California
View Study & Checklist ➔A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
📍 Abramson Cancer Center at University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
📍 Duke Cancer Center — Durham, North Carolina
View Study & Checklist ➔A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
📍 GSK Investigational Site — Los Angeles, California
View Study & Checklist ➔Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
📍 Call for Information (Investigational Site 0019) — Aurora, Colorado
View Study & Checklist ➔A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
📍 James Graham Brown Cancer Center-University of Louisville — Louisville, Kentucky
View Study & Checklist ➔A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
📍 Research Site — Grand Rapids, Michigan
View Study & Checklist ➔A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
📍 Arizona Cancer Center at UMC North/University Medical Center — Tucson, Arizona
View Study & Checklist ➔